Health Care

Cape Fear Valley Ear, Nose & Throat completes first Inspire therapy procedure

By Staff Report, posted 1 year ago
 From left to right: Nurse Deandra Jacobs, Surgical Technologist Jayla Malloy, Dr. Jennifer Tartaglia and Surgical Technologist III Cynthia Mcintrye stand outside an operating room after the first Inspire procedure was completed March 12.
Photo provided by: CFVH 

Jennifer Tartaglia, M.D., of Cape Fear Valley Ear, Nose & Throat has completed the first Inspire procedure at Cape Fear Valley Ear, Nose & Throat. Inspire is an FDA-approved obstructive sleep apnea (OSA) treatment option for people who cannot use Continuous Positive Airway Pressure (CPAP) therapy.

OSA affects 22 million Americans. When left untreated, OSA can cause vehicle and workplace accidents, worsening mood and memory, stroke, heart attack and even death. It occurs when the airway collapses during sleep and blocks the flow of oxygen to the brain. The brain senses a lack of oxygen and wakes the body up just long enough to take a breath, then falls back asleep. This cycle repeats throughout the night and causes poor, disruptive sleep.

Inspire works inside the body with a patient’s natural breathing process to treat sleep apnea. Mild stimulation opens the airway during sleep, allowing oxygen to flow naturally. The patient uses a small handheld remote to turn Inspire on before bed and off when they wake up.

The Inspire system is implanted during a short, outpatient procedure. The system is placed under the skin of the neck and chest through two small incisions. Most patients return home the same day and take over-the-counter pain medications to manage pain as needed.

The safety and efficacy of Inspire was evaluated during the STAR clinical trial. Five-year STAR trial outcomes show patients using Inspire experience significant reductions in sleep apnea events and significant improvements in quality-of-life measures. There have been over 150 peer-reviewed publications on Inspire. These publications show results consistent with those seen in the STAR trial.

“We are excited to have completed the first Inspire procedure at CENTER,” said Dr. Tartaglia in a press release. “Inspire represents a significant advancement in treating sleep apnea. It is clinically proven to reduce sleep apnea events, has a high level of patient satisfaction and a high therapy adherence.”

To learn more about Inspire, please visit InspireSleep.com or capefearvalley.com/sleep.

Ico insights

INSIGHTS

SPONSORS' CONTENT

In The Current Issue

A salute to service: LTG Braga relinquishes USASOC command

U.S. Army Special Operations Command Acting Commanding General, Brig. Gen. Kirk Brinker, gives a speech as USASOC bids farewell to Lt. Gen. Jonathan Braga after serving four years as its commanding general outside the USASOC Headquarters at Fort Brag


Fall for Dogwood: The Fayetteville Dogwood Fall Festival returns in 2025

Graphic provided by Fayetteville Dogwood FestivalGood music, food and fall themed fun for all ages will swirl into Festival Park with the falling leaves this season. On Oct. 18 and 19, The Dogwood Festival will be returning for the fall. This free fe


Lending perspectives: Local banks respond to recent federal rate cuts

 Chair Powell answers reporters' questions at the FOMC press conference on Sept. 17, 2025. Photo provided by the Federal Reserve.On Wednesday, Sept. 17, the Federal Open Market Committee (FOMC) announced that it had decided to lower the target r